Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Plasma cell 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Lung Neoplasms 11Breast Neoplasms 10Prostatic Neoplasms 7Colorectal Neoplasms 7Pancreatic Neoplasms 3Ovarian Neoplasms 3Hematopoietic and Lymphatic System Neoplasm 3Hematologic Neoplasms 3Advanced Malignant Solid Neoplasm 3Skin Carcinoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Obesity-Related Malignant Neoplasm 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Malignant Solid Neoplasm 2Lymphoma 2Leukemia, Myeloid, Acute 2Carcinoma, Non-Small-Cell Lung 2Anatomic Stage I Breast Cancer AJCC v8 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Syndrome 1Substance-Related Disorders 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Psoriasis 1Primary Myelofibrosis 1

Interventions

Cyclophosphamide 15fludarabine 12Mycophenolic Acid 10Standard of Care 9Whole-Body Irradiation 7Tacrolimus 7venetoclax 6Specimen Handling 6Sirolimus 6Practice Guidelines as Topic 6trametinib 5Melphalan 5fludarabine phosphate 4Mesna 4Magnetic Resonance Spectroscopy 4Filgrastim 4Biopsy 4Behavior Therapy 4Azacitidine 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3GSK2636771 3Educational Status 3Crizotinib 3Busulfan 3thymoglobulin 2talquetamab 2ruxolitinib 2palbociclib 2osimertinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Educational Status × 90 days × Clear all
NCT04630431 2026-06-04

Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients

Mayo Clinic

Phase NA Terminated
590 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT04960787 2026-05-14

CREDIT

SWOG Cancer Research Network

Phase NA Active not recruiting
331 enrolled
Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

NCT05972577 2026-04-06

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡